サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631171

髄膜炎診断検査の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Meningitis Diagnostic Testing Market Size, Share & Trends Analysis Report By Type (Latex Agglutination Tests, Lateral Flow Assay), By End Use (Hospitals, Diagnostic Centers), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
髄膜炎診断検査の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年12月09日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

髄膜炎診断検査市場の成長と動向

Grand View Research, Incの最新レポートによると、世界の髄膜炎診断検査市場規模は2030年までに1億5,590万米ドルに達し、2025～2030年のCAGRは3.9％を記録すると予測されています。

同市場の成長は、疾病の早期診断に対する人々の意識の高まりと、検査の高精度と相まって迅速診断に対する需要の高まりに起因しています。さらに、疾病の負担を軽減するための政府支援の増加や診断センターの増加も、市場の需要を促進する要因となっています。

感染症やHIVの流行の増加は髄膜炎を発症するリスクを高めており、髄膜炎診断検査に対する需要を世界中で高めています。例えば、WHOによると、2021年には世界で3,840万人以上がHIVに感染しています。また、CDCによると、2020年には米国で約3万635人がHIVの診断を受けています。さらに、EV髄膜炎は米国で毎年約3万～5万人の入院を引き起こすと推定されています。

従って、このような対象疾患の高い発生率が、メーカーに正確な診断ソリューションの開発を促しています。例えば、Cepheidは、最適な感度と特異度で2.5時間で結果が得られる、高速分子体外診断用EV検査であるXpert EVを提供しました。同様に、Diagenode DiagnosticsのM-DiaMultはPCR-CE-IVDキットの一種で、髄膜炎菌を含む多くの細菌感染を検出します。

髄膜炎感染は、その長期にわたる影響と高い死亡率により、世界の問題として浮上しています。政府は、髄膜炎を根絶するために、先進的診断テストと治療レジメンを提供する積極的な支援を行っています。例えば、髄膜炎研究財団やCDCは、結核、マラリア、髄膜炎など、病院では受けることのできないさまざまな感染症の診断を発表しています。このように、様々な感染症の診断を促進する政府の取り組みは、市場に有利な成長機会を提供する可能性が高いです。

さらに、医療セグメントの開発の急増と診断検査における技術進歩の拡大は、市場に力強い成長機会を提供する可能性が高いです。例えば、2022年7月、分子診断検査のリーダーであるAbacus Diagnosticaは、脳炎や髄膜炎を引き起こすウイルスを迅速に同定するための新しい迅速PCR検査を欧州市場で発売しました。この新発売の検査により、医療専門家は髄膜炎を引き起こす最も一般的なウイルスを70分で同定することができます。精度の高い迅速検査の採用は、今後数年間の市場成長を促進すると予想されます。

髄膜炎診断検査市場レポートハイライト

  • PCR検査が好まれ、感度が高く、検査所要時間が短いことから、PCR検査セグメントが2024年に最大の市場シェアを占めました。
  • ラテラルフローアッセイは、さまざまな医療施設での迅速検査の採用が増加しているため、今後数年間は最も速いセグメントとなる見込みです。
  • 病院部門は基準年の売上貢献のトップであり、その高収益は新しい診断技術へのアクセスの増加と医療保障の向上に起因しています。
  • 診断センターセグメントは、感染症負担の急増と技術的に先進的な製品の採用増加により、最も速い成長率を示すと予想されます。
  • アジア太平洋は、同地域における投資の増加と進行中の臨床検査により、予測期間中に最も速い成長を示すと予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 髄膜炎診断検査市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 髄膜炎診断検査市場：タイプ別ビジネス分析

  • タイプ別市場シェア、2024年と2030年
  • タイプセグメントダッシュボード
  • 市場規模と予測と動向分析、タイプ別、2018～2030年
  • ラテックス凝集検査
  • ラテラルフローアッセイ
  • PCRアッセイ
  • ELISA検査
  • 文化テスト
  • その他

第5章 髄膜炎診断検査市場：最終用途別ビジネス分析

  • 最終用途別市場シェア、2024年と2030年
  • 最終用途セグメントダッシュボード
  • 市場規模と予測と動向分析、最終用途別、2018～2030年
  • 病院
  • 診断センター
  • その他

第6章 髄膜炎診断検査市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模と予測動向分析、2018～2030年
  • 北米
    • 国別、2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc
    • Abbott.
    • ELITechGroup
    • Seegene Inc.
    • DiaSorin SpA
    • CERTEST BIOTEC.
    • IMMY.
    • Uniogen Oy
    • BIOMERIEUX
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global meningitis diagnostic testing market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 U.S meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 U.S meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 14 Mexico meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mexico meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Europe meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 18 Europe meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Germany meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 22 Germany meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 23 France meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 24 France meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Spain meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 28 Spain meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Norway meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 30 Norway meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Sweden meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 34 Sweden meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Japan meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 39 Japan meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 China meningitis diagnostic testing market, by type, 2018-2030 (USD Million)
  • Table 41 China meningitis diagnostic testing market, by end use, 2018-2030 (USD Million)
  • Table 42 India meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 43 India meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Australia meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 Australia meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 46 South Korea meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 47 South Korea meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Thailand meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 49 Thailand meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Latin America meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
  • Table 51 Latin America meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 52 Latin America meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Brazil meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 54 Brazil meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Argentina meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 56 Argentina meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 59 Middle East & Africa meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Africa meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Africa meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 64 UAE meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 65 UAE meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Kuwait meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 67 Kuwait meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Meningitis diagnostic testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Meningitis diagnostic testing market dynamics
  • Fig. 13 Meningitis diagnostic testing market: Porter's five forces analysis
  • Fig. 14 Meningitis diagnostic testing market: PESTLE analysis
  • Fig. 15 Meningitis diagnostic testing market: Type segment dashboard
  • Fig. 16 Meningitis diagnostic testing market: Type market share analysis, 2024 & 2030
  • Fig. 17 Latex agglutination tests market, 2018 - 2030 (USD Million)
  • Fig. 18 Lateral flow assay market, 2018 - 2030 (USD Million)
  • Fig. 19 PCR assay market, 2018 - 2030 (USD Million)
  • Fig. 20 ELISA tests market, 2018 - 2030 (USD Million)
  • Fig. 21 Culture test market, 2018 - 2030 (USD Million)
  • Fig. 22 Others market, 2018 - 2030 (USD Million)
  • Fig. 23 Meningitis diagnostic testing market: End use segment dashboard
  • Fig. 24 Meningitis diagnostic testing market: End use market share analysis, 2024 & 2030
  • Fig. 25 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 26 Diagnostic centers market, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Meningitis diagnostic testing market revenue, by region
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 North America meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. country dynamics
  • Fig. 32 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada country dynamics
  • Fig. 34 Canada meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico country dynamics
  • Fig. 36 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 38 UK country dynamics
  • Fig. 39 UK meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany country dynamics
  • Fig. 41 Germany meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 42 France country dynamics
  • Fig. 43 France meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy country dynamics
  • Fig. 45 Italy meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain country dynamics
  • Fig. 47 Spain meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway country dynamics
  • Fig. 49 Norway meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD Million
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 55 Japan country dynamics
  • Fig. 56 Japan meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 57 China country dynamics
  • Fig. 58 China meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 59 India country dynamics
  • Fig. 60 India meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea country dynamics
  • Fig. 62 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand country dynamics
  • Fig. 66 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil country dynamics
  • Fig. 69 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 70 Argentina country dynamics
  • Fig. 71 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 72 MEA meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 73 South Africa country dynamics
  • Fig. 74 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia country dynamics
  • Fig. 76 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 77 UAE country dynamics
  • Fig. 78 UAE meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 79 Kuwait country dynamics
  • Fig. 80 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 81 Company categorization
  • Fig. 82 Company market position analysis
  • Fig. 83 Strategic framework
目次
Product Code: GVR-4-68040-009-0

Meningitis Diagnostic Testing Market Growth & Trends:

The global meningitis diagnostic testing market size is expected to reach USD 155.9 million by 2030, according to a new report by Grand View Research, Inc, registering a CAGR of 3.9% from 2025 to 2030. The growth of the market is accredited to the rising awareness among the people about early disease diagnosis and increasing demand for rapid diagnosis coupled with the high accuracy of the test. Moreover, the increasing government support to reduce the burden of disease and the rising number of diagnostic centers are other factors fueling market demand.

The increasing prevalence of infectious diseases, and HIV is increasing the risk of developing meningitis, which is increasing the demand for meningitis diagnostic tests, worldwide. For instance, according to the WHO, over 38.4 million people were living with HIV worldwide in 2021. In addition, according to CDC in 2020, around 30,635 people received HIV diagnoses in the U.S. High number of HIV infections may increase the testing rate for meningitis. Moreover, EV meningitis is estimated to result in around 30,000-50,000 hospitalizations every year in the U.S.

Thus, such a high incidence of target diseases is pushing manufacturers to develop precise diagnostic solutions. For instance, Cepheid offered Xpert EV, a fast molecular in vitro diagnostic EV test, which provides results in 2.5 hours with optimum sensitivity and specificity. Similarly, M-DiaMult of Diagenode Diagnostics is a type of PCR- CE-IVD kit that detects many bacterial infections including Neisseria meningitidis.

Meningitis infection has emerged as a global issue owing to its long-term consequences and high mortality rate. The government is offering active support to provide sophisticated diagnostic tests and treatment regimens to eradicate the disease. For instance, the Meningitis Research Foundation and the CDC offer referral diagnoses for different infectious diseases such as tuberculosis, malaria, and meningitis among others that are not available in hospitals. Thus, such government initiatives to promote the diagnosis of various infectious diseases are likely to offer lucrative growth opportunities for the market.

Furthermore, the surge in the healthcare sector developments and growing technological advancements in diagnostic tests are likely to offer robust growth opportunities for the market. For instance, in July 2022, Abacus Diagnostica, a leader in molecular diagnostic testing, launched a novel rapid PCR test in Europe markets for the quick identification of viruses causing encephalitis and meningitis. This newly launched test allows healthcare professionals to identify the most common virus those causes meningitis in a span of 70 minutes. The introduction of rapid tests with high accuracy is anticipated to propel the market growth in the coming years.

Meningitis Diagnostic Testing Market Report Highlights:

  • PCR assay segment held the largest market share in 2024 owing to a high preference for PCR tests and higher sensitivity and lower turnaround times of the test.
  • Lateral flow assay is expected to be the fastest segment during the coming years due to the increasing adoption of rapid tests at different healthcare facilities.
  • Hospitals segment was the leading revenue contributor during the base year and its high revenue is attributed to increasing access to novel diagnostic technologies and improved healthcare coverage.
  • The diagnostic centers segment is anticipated to exhibit the fastest growth rate owing to the surge in the burden of infectious diseases and the increasing adoption of technologically advanced products.
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period due to rising investments in the region and ongoing trials in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Meningitis Diagnostic Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Meningitis Diagnostic Testing Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Latex Agglutination Tests
    • 4.4.1. Latex Agglutination Tests Market, 2018 - 2030 (USD Million)
  • 4.5. Lateral Flow Assay
    • 4.5.1. Lateral Flow Assay Market, 2018 - 2030 (USD Million)
  • 4.6. PCR Assay
    • 4.6.1. PCR Assay Market, 2018 - 2030 (USD Million)
  • 4.7. ELISA Tests
    • 4.7.1. ELISA Tests Market, 2018 - 2030 (USD Million)
  • 4.8. Culture Test
    • 4.8.1. Culture Test Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Meningitis Diagnostic Testing Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 5.5. Diagnostic Centers
    • 5.5.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Meningitis Diagnostic Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Canada Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Thermo Fisher Scientific Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Type Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Bio-Rad Laboratories, Inc
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Type Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Abbott.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Type Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. ELITechGroup
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Type Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Seegene Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Type Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. DiaSorin S.p.A.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Type Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. CERTEST BIOTEC.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Type Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. IMMY.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Type Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Uniogen Oy
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Type Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. BIOMERIEUX
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Type Benchmarking
      • 7.5.10.4. Strategic Initiatives